SARASOTA, Fla., Nov. 7 Rapid Pathogen Screening Inc.,(RPS) -- a leading developer of point-of-care diagnostic devices for oculardiseases -- announced today that the American Medical Association will issue anew Current Procedural Terminology (CPT) code that will cover the RPS AdenoDetector(TM), effective January 1, 2008. CPT Code 87809 -- a code for"Infectious agent antigen detection by immunoassay with direct opticalobservation; Adenovirus" -- will cover the RPS Adeno Detector(TM).
The RPS Adeno Detector(TM) is the first true point-of-care test availablefor conjunctivitis -- more commonly known as "pink eye." Cleared by the Foodand Drug Administration (FDA) and waived under the Clinical LaboratoryImprovement Amendments of 1988 (CLIA), this test is highly sensitive andspecific, and it provides a definitive result in 10 minutes. The publicationof this CPT code will expand the use of the RPS Adeno Detector(TM) and equiphealth care providers with this necessary tool to make an accurate laboratoryconfirmation of adenoviral conjunctivitis at the time of the patient exam.
"The creation of a new CPT code reflects the value that the RPS AdenoDetector(TM) provides to the patient, the clinician and the healthcare systemat large," stated Robert Sambursky, MD, Chief Medical Officer of RPS. "Withthe CPT code, clinicians may use the RPS Adeno Detector(TM) to accuratelydiagnose and treat cases of acute conjunctivitis. This will not only result inbetter patient care; it also will save millions in health care dollars. If allcases of acute conjunctivitis were diagnosed with the RPS Adeno Detector(TM),the Health Economics Consulting Group, LLC (HECG) estimates that the U.S.healthcare system would save more than $460 million each year."
The RPS Adeno Detector(TM) not only allows for accurate and earlydiagnosis of pink eye thereby mitigating the spread of this often contagiousdisease, but it also reduces the over-prescription of antibiotics -- to whichAmericans have become more resistant as documented by recent medical reports.
About the RPS Adeno Detector(TM)
The RPS Adeno Detector(TM) is the first in a family of RPS point-of-carediagnostic devices. As a rapid, in-office, immunodiagnostic test for detectingthe presence of adenoviral antigens, the RPS Adeno Detector(TM) meets thecriteria established within the October 2006 Preferred Practice Pattern(TM) onConjunctivitis from the American Academy of Ophthalmology. The test iscurrently being used as point-of-care test in many optometry and ophthalmologyoffices, family practice and pediatric offices, as well as on military basesand other centers for care across the United States.
About the Code
CPT codes are published by the American Medical Association, and each codeis a five digit numeric code used to provide uniform language that accuratelydescribes medical, surgical, radiology, laboratory, anesthesiology, andevaluation/management services of physicians, hospitals, and other health careproviders. There are approximately 7,800 CPT codes.About RPS: To learn more about RPS, please visit: http://www.rps-tests.com Contact: Dan Maloy Rapid Pathogen Screening, Inc. 941-556-1855 firstname.lastname@example.org www.rps-tests.com
SOURCE Rapid Pathogen Screening Inc.